MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY

被引:1250
作者
BARAK, Y
JUVEN, T
HAFFNER, R
OREN, M
机构
[1] Department of Chemical Immunology, The Weizmann Institute of Science
关键词
GROWTH CONTROL; MDM2; P53; TUMOR SUPPRESSOR;
D O I
10.1002/j.1460-2075.1993.tb05678.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently characterized a 95 kDa protein, p95, which exhibits enhanced binding to temperature-sensitive p53 (ts-p53) when cells are shifted down to 32.5-degrees-C, a temperature at which ts-p53 possesses wild-type (wt)-like activities. In the present study we show that p95 is a product of the mdm2 putative proto-oncogene. The enhanced complex formation of mdm2 with ts-p53 in cells maintained at 32.5-degrees-C is due to an elevation in total mdm2 protein levels following the temperature shift. We further demonstrate that the induction of mdm2 expression by wt p53 activity is at the mRNA level. The induction occurs with very rapid kinetics and does not require de novo protein synthesis, suggesting a direct involvement of p53 in the process. Based on these data and on recent findings implicating p53 as a transcription factor, we suggest that the mdm2 gene is a target for activation by wt p53. In view of the ability of mdm2 to act as a specific antagonist of p53 activity, this induction process may serve to tightly autoregulate p53 activity in living cells.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 62 条
[21]   DIFFERENT TUMOR-DERIVED P53 MUTANTS EXHIBIT DISTINCT BIOLOGICAL-ACTIVITIES [J].
HALEVY, O ;
MICHALOVITZ, D ;
OREN, M .
SCIENCE, 1990, 250 (4977) :113-116
[22]  
HARLOW E, 1981, J VIROL, V34, P752
[23]  
HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571
[24]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[25]  
KASTAN MB, 1991, CANCER RES, V51, P6304
[26]   IDENTIFICATION OF P53 AS A SEQUENCE-SPECIFIC DNA-BINDING PROTEIN [J].
KERN, SE ;
KINZLER, KW ;
BRUSKIN, A ;
JAROSZ, D ;
FRIEDMAN, P ;
PRIVES, C ;
VOGELSTEIN, B .
SCIENCE, 1991, 252 (5013) :1708-1711
[27]   ONCOGENIC FORMS OF P53 INHIBIT P53-REGULATED GENE-EXPRESSION [J].
KERN, SE ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
SEYMOUR, A ;
KINZLER, KW ;
VOGELSTEIN, B .
SCIENCE, 1992, 256 (5058) :827-830
[28]   WILD-TYPE P53 IS A CELL-CYCLE CHECKPOINT DETERMINANT FOLLOWING IRRADIATION [J].
KUERBITZ, SJ ;
PLUNKETT, BS ;
WALSH, WV ;
KASTAN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7491-7495
[29]   CANCER - P53, GUARDIAN OF THE GENOME [J].
LANE, DP .
NATURE, 1992, 358 (6381) :15-16
[30]   HUMAN PAPILLOMAVIRUS E6 PROTEINS BIND P53 INVIVO AND ABROGATE P53-MEDIATED REPRESSION OF TRANSCRIPTION [J].
LECHNER, MS ;
MACK, DH ;
FINICLE, AB ;
CROOK, T ;
VOUSDEN, KH ;
LAIMINS, LA .
EMBO JOURNAL, 1992, 11 (08) :3045-3052